Skip to content
ppharmaranks
Menu
Class IIOngoing

chloroproMAZINE Hydrochloride Tablets recall

FDA recall D-0643-2025 · initiated Aug 25, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 17, 2025How we research

AvKARE recalled chloroproMAZINE Hydrochloride Tablets in Aug 2025 — an FDA Class II recall (D-0643-2025) because Presence of a foreign substance.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of a foreign substance.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25

Quantity recalled: 1512 cartons

Details

Product
chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA Nationwide
Initiated
Aug 25, 2025
FDA report date
Sep 17, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was chloroproMAZINE Hydrochloride Tablets recalled?
AvKARE recalled chloroproMAZINE Hydrochloride Tablets in Aug 2025 — an FDA Class II recall (D-0643-2025) because Presence of a foreign substance. May cause temporary or medically reversible harm; low probability of serious harm.
Why was chloroproMAZINE Hydrochloride Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0643-2025 was: Presence of a foreign substance.
Is a recalled chloroproMAZINE Hydrochloride Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of chloroproMAZINE Hydrochloride Tablets are affected?
Distributed: USA Nationwide. The recall covers these lots — Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0643-2025.

Source: openFDA Drug Enforcement record D-0643-2025

← All drug recalls